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Background: A total of 22 priority countries have been identified by the WHO that account for 90% of pregnant
women living with HIV. Nigeria is one of only 4 countries among the 22 with an HIV testing rate for pregnant
women of less than 20%. Currently, most pregnant women must access a healthcare facility (HF) to be screened
and receive available prevention of mother-to-child HIV transmission (PMTCT) interventions. Finding new
approaches to increase HIV testing among pregnant women is necessary to realize the WHO/ President's
Emergency Plan for AIDS Relief (PEPFAR) goal of eliminating new pediatric infections by 2015.
Methods: This cluster randomized trial tests the comparative effectiveness of a congregation-based Healthy
Beginning Initiative (HBI) versus a clinic-based approach on the rates of HIV testing and PMTCT completion among
a cohort of church attending pregnant women. Recruitment occurs at the level of the churches and participants
(in that order), while randomization occurs only at the church level. The trial is unblinded, and the churches are
informed of their randomization group. Eligible participants, pregnant women attending study churches, are
recruited during prayer sessions. HBI is delivered by trained community health nurses and church-based health
advisors and provides free, integrated on-site laboratory tests (HIV plus hemoglobin, malaria, hepatitis B, sickle cell
gene, syphilis) during a church-organized ‘baby shower.’ The baby shower includes refreshments, gifts exchange,
and an educational game show testing participants’ knowledge of healthy pregnancy habits in addition to HIV
acquisition modes, and effective PMTCT interventions. Baby receptions provide a contact point for follow-up after
delivery. This approach was designed to reduce barriers to screening including knowledge, access, cost and stigma.
The primary aim is to evaluate the effect of HBI on the HIV testing rate among pregnant women. The secondary
aims are to evaluate the effect of HBI on the rate of HIV testing among male partners of pregnant women and the
rate of PMTCT completion among HIV-infected pregnant women.
Discussion: Results of this study will provide further understanding of the most effective strategies for increasing
HIV testing among pregnant women in hard-to-reach communities.
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Globally, Sub-Saharan Africa (SSA) accounts for 76% of
all women living with HIV and an estimated 90% of the
3.4 million children living with HIV. A total of 22 prio-
rity countries have been identified by the WHO that
account for 90% of pregnant women living with HIV.
Nigeria is one of only 4 countries among the 22 with
an HIV testing rate for pregnant women of less than
20% [1,2]. Studies have shown that when HIV-infected
women are treated with antiretroviral therapy and their
infants receive antiretroviral (ARV) prophylaxis, mother-
to-child transmission of HIV (MTCT) occurs in less
than 1% of pregnancies [3-6]. Despite the availability of
simple, less expensive and highly effective ARV regimens
capable of being implemented in resource-limited set-
tings, 75,000 Nigerian infants were infected in 2010
[1,7]. During that year, only 14% of pregnant women
were tested for HIV, while 9% of pregnant women living
with HIV received WHO recommended antiretroviral
(ARV) therapy, and only 11% of HIV-exposed infants
received ARV prophylaxis for prevention of mother-to-
child HIV transmission (PMTCT) resulting in an estima-
ted 75,000 HIV-infected infants in 2010 [1,8]. Currently,
most pregnant women must access a healthcare facility
(HF) to be screened and receive available PMTCT in-
terventions. This clinic-based approach is challenging
when only 35% of pregnant women deliver in an HF and
only 2.9% of HFs have an established PMTCT program
[8,9]. Finding new approaches to translate evidence-based
interventions in PMTCT to sustainable community-based
programs is necessary to realize the WHO/PEPFAR goal
of eliminating new pediatric infections by 2015 [10].
Various reasons have been identified as barriers to
HIV testing and PMTCT completion. Low perception of
personal risk, poor access to testing sites, cost, confiden-
tiality, and HIV-related stigma have all been identified as
barriers to HIV testing [11-14]. Barriers to optimal
PMTCT exist at the level of the patients and providers,
but barriers at the health systems level appear to have
more adverse impact on healthcare in general [15-17].
Most women in Nigeria do not access prenatal care early
in pregnancy, and only 35% of pregnant women deliver
in a health facility where just 2.9% have an established
PMTCT program [9,18,19]. When community testing
has been implemented to increase testing rate, the ex-
tensive attrition that takes place between HIV testing
and treatment leads to people informed of their HIV-
positive status failing to be adequately linked with ap-
propriate services [20].
The late initiation of prenatal care results in missed
opportunities for repeat testing, an important factor in
PMTCT, as a significant proportion of pregnant women
are in HIV-discordant relationships and testing rates
are low among adult males, which could result in sero-conversions late in pregnancy [21-24]. Failure to disclose
HIV sero-status is another barrier that hinders PMTCT
completion, as studies have shown that women who do
not disclose their sero-status to their male partners are
less likely to complete interventions for PMTCT [25-27].
Male partner involvement has been shown to positively
impact PMTCT, but asking or requiring pregnant wo-
men to recruit their male partners for HIV testing crea-
tes a barrier to partner testing, even though there is an
increased willingness to test for HIV when pregnant
women are tested at the same time with their male part-
ners [28-31]. Despite these barriers, HIV testing exceeds
80% when pregnant women become aware of the effect-
iveness of interventions that assist in preventing MTCT
and testing materials are available even in the presence
of high anticipations of HIV/AIDS stigma [32-35].
Three viable and potentially cost-effective strategies
for mitigating systems-level barriers to optimal testing
and PMTCT completion include: decentralizing testing
beyond health facilities [36,37], improving access to tes-
ting and treatment services, and identifying other de-
livery models that reduces loss to follow-up by linking
testing sites to treatment centers [38-41].
Finding new approaches to translate evidence-based
PMTCT programs to community-based settings is ne-
cessary if we are to realize the PEPFAR goal of 80% HIV
screening rate among pregnant women by 2015 [10]. For-
tunately, the government of Nigeria, in its 2010–2015
National Strategic Framework (NSF), identified reduction
in new infections as a major goal [42]. It plans to increase
access to quality HIV testing and ARV treatment for at
least 80% of HIV-infected pregnant women. To achieve
this, the framework calls for strengthening private
sector engagement in expanding PMTCT interventions
to community-based programs to complement existing
clinic-based testing.
This study is one of few cluster randomized clinical
trials of the effectiveness of congregation-based approach
in hard-to-reach rural communities. We are reporting this
method because it could serve as a model for other inter-
ventions aimed at improving maternal-child health out-
comes in these communities.
Study aims and hypothesis
The objective of this trial is to test the comparative ef-
fectiveness of a congregation-based Healthy Beginning
Initiative (HBI) that promotes individual testing and uti-
lizes the church network for subject tracking and reten-
tion versus a clinic-based approach in increasing HIV
testing and PMTCT completion among 2,700 pregnant
women and male partners attending 40 churches in
Southeast Nigeria. We considered randomizing each in-
dividual patient, but the likelihood of contamination po-
ses a threat to internal validity; thus, individual pregnant
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sidered a crossover design, but the possibility of with-
drawing an intervention if it becomes effective would
make this design problematic.
Primary aim
The primary aim is to evaluate the effect of HBI on the
HIV testing rate among pregnant women.
Secondary aims
The secondary aims are to evaluate the effect of HBI on
the rate of HIV testing among male partners of pregnant
women and the rate of PMTCT completion among HIV-
infected pregnant women.
Hypotheses
We hypothesized that pregnant women randomized to
the intervention group (IG) compared to those random-
ized to control group (CG) will have a higher rate of
HIV testing, a higher rate of HIV testing among male
partners, and a higher PMTCT completion rate among
HIV-infected pregnant women. This study is one of few
randomized trials to test the effectiveness of such a




Using a two-arm cluster randomized trial design, we will
evaluate the effect of a congregation-based HBI that pro-
vides free, integrated on-site laboratory tests during a
church-organized baby shower as the IG versus clinic-
based approach as the CG on the rate of HIV testing
among pregnant women, their male partners, and the
PMTCT completion rate among HIV-infected pregnant
women. A total of 40 churches in Enugu State, south-
east Nigeria, will be randomly assigned to either the IG
(N = 20 churches) or the CG (N = 20 churches). A totalFigure 1 Overview of the healthy beginning initiative.of 2,700 pregnant women will be enrolled in this study,
with about 8 to 16 pregnant women each month per
church (depending on the size of the church) enrolled
each month over a 5-month period. Participants in
churches randomized to the CG will be referred to the
closest healthcare facility for HIV testing and prenatal
care. Participants in churches randomized to IG will re-
ceive health education and be offered an HIV test as part
of an integrated laboratory test on-site at the church
during a baby shower program. The primary outcome is
difference in the rate of HIV testing between both
groups. The secondary outcomes are the difference in
the rate of HIV testing among male partners, and the
PMTCT completion rate among HIV-infected pregnant
women in both groups. Pregnant women will complete
an investigator-administered questionnaire to collect in-
formation on HIV testing and PMTCT completion. Self-
reported HIV testing and PMTCT completion will be
confirmed with the healthcare facility for participants in
churches randomized to the CG, and with on-site HIV
testing data and the healthcare facility (PMTCT comple-
tion) for participants in churches randomized to the IG
(Figure 1). Participants in churches randomized to CG
will have two study visits: baseline (recruitment) and six
to eight weeks after delivery. Participants in churches
randomized to IG will have three study visits; baseline
(recruitment), baby shower and six to eight weeks after
delivery.
Study setting and participants
We selected Enugu State as the site for the proposed
study for three reasons: first, its population is culturally
and ethnically related and predominately Christian, with
church attendance approaching 90% [43-44]. Second,
the overall state HIV sero-prevalence of 5.1% is close to
the national average of 4.1% [8]. Third, the churches that
we propose to use as study sites are widely distributed
in Enugu and Oji-River areas, and represent variations
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(6% average) [8]. Any self-identified pregnant woman at-
tending any of the study sites is eligible to participate.
Women are encouraged to participate with their male
partners, but can still participate if the male partner
chooses not to participate. The study was approved by
the Institutional Review Board of the University of Nev-
ada, Reno, and the Nigerian National Health Research
Ethics Committee.
Church recruitment and randomization
Recruitment occurred at the level of the churches and
participants (in that order), while randomization oc-
curred only at the church level. A total of 40 churches
selected from four dioceses (the Anglican diocese of
Enugu, the Catholic diocese of Enugu, the Anglican dio-
cese of Oji-River, and the Catholic diocese of Agwu)
were randomized to either the IG or the CG. All of the
bishops who oversee churches in the proposed study
areas had previously agreed to participate in this study
and gave the study team access to speak to the priests
under their dioceses. Randomization of churches occur-
red in 4 cohorts of 10 churches following random ran-
king. The churches were randomized in a 1:1 ratio to
either the IG or CG. The sequence of randomization
was generated by Dr Yang and kept in a sealed opaque
envelop away from the study sites in accordance with
CONSORT guidelines [45]. Once the sites had been
recruited and baseline information on churches collected
(e.g., type, size of congregation), the sites were informed
of their randomization group and assigned a code. Be-
cause of the nature of the intervention, it was impossible
to blind the participants, community health nurses, lay
health advisors, and study coordinators to the group as-
signment, but the test results cannot be influenced by
the study coordinators.
Staff recruitment and training
Prevention, education, treatment, Training and Research-
Global Solutions (PeTR-GS), our local PEPFAR-supported
partner working with the Sunrise Foundation, conducted
training workshops for all study staff and church-based
lay health advisors. They received training on the study
protocol, including how to obtain informed consent, data
collection forms, and confidentiality. Additionally, study
staff received information on HIV counseling, delivering
HIV test results and post-test counseling. Although priests
are not involved in the active intervention, they also re-
ceived information focused on basic HIV transmission,
MTCT and PMTCT that will be useful should any partici-
pant identified as HIV-infected request counsel from the
priest. Attempts were made to preferentially recruit indi-
viduals who have previously completed HIV training pro-
grams through PeTR-GS or other agencies to reduce thetime spent in training. The training was a modified format
used by PeTR-GS for national HIV counseling and testing
training.
Participant recruitment
Recruitment began following randomization of the chur-
ches. Each Sunday, the priest asks pregnant women and
their male partners in the congregation to step to the
altar for prayers. He prays for a healthy pregnancy, suc-
cessful delivery, and encourages pregnant women to seek
care at a health facility during their pregnancy. He intro-
duces the concept of the Healthy Beginning Initiative
and study team as a program supporting pregnant wo-
men in the congregation during pregnancy. Pregnant
women and their male partners are encouraged to par-
ticipate. Pregnant women who consent can participate in
the study, even when the male partner is unavailable or
chooses not to participate.
Description of the intervention
Intervention is focused on removing system-level barriers
to HIV testing and making tests available to pregnant
women where they congregate as close to their home
environment as possible. Conducted as part of a church-
organized, family-oriented baby shower program that cele-
brates pregnancy and childbirth, the integrated approach
to laboratory tests could potentially reduce the stigma as-
sociated with an HIV-only test approach (Figure 2).
Description of the control condition/usual care
Participants in churches randomized to CG also follow
the three steps of priest-directed prayer sessions, baby
shower, and a church-organized baby reception. An edu-
tainment game and free integrated on-site laboratory
tests are not offered during the baby shower for this
group. Pregnant women were encouraged to attend pre-
natal care through the health facilities. Participants also
complete a post-delivery questionnaire. The research team
maintains direct contact with health facilities to confirm
HIV testing and PMTCTcompletion.
Outcome measures
The primary outcome measure is HIV testing for preg-
nant women and pertains to both the cluster and indi-
vidual participant level. Post-delivery questionnaires will
be used to ascertain HIV testing during pregnancy. HIV
testing during pregnancy will be confirmed through the
integrated laboratory testing at churches randomized to
IG. HIV testing among women in churches randomized
to CG will be confirmed at the health facility where
pregnant women reported prenatal care. The secondary
outcomes are male partner HIV testing and PMTCT
completion among HIV-infected women, and pertain to
both the cluster and individual participant level.
Figure 2 Summary of intervention activities.
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The proposed study is a two-arm cluster randomized
controlled trial with the church as the unit of rando-
mization. Thus, there are two important sample size es-
timates: N, the number of pregnant women; and K, the
number of churches, with the pregnant women nested
within the K churches. We reviewed the total annual
infant baptisms in churches located in Enugu and Oji-
River for 2010 to estimate the potential number of preg-
nant women. Our review indicated that there were
20,700 infant baptisms conducted in 2010. Further ana-
lysis showed that in 2010, Enugu and Oji-River each
contained about 50 churches that had 200 infant bap-
tisms and 40 churches that had at least 100 infant
baptisms (Table 1).
Power calculations were performed using the module
‘Inequality Tests for Two Proportions in a Cluster-
Randomized Design’ in PASS 11, which implements me-
thods of Donner and Klar [46]. That module approximatesTable 1 Infant baptisms in churches
Enugu Local Government Area Oji-River Local Government Area
Catholic Churches: 9,300 infant
baptisms
Catholic Churches: 9,000 infant
baptisms
Anglican Churches: 1,400 infant
baptisms
Anglican Churches: 1,000 infant
baptismspower for simple two-sample binomial tests for data col-
lected in clusters with non-zero intra-cluster correlation
(ICC). The Proc GLIMMIX analysis should have superior
power since inclusion of covariates should reduce variabi-
lity. For all three hypotheses, there will be 40 clusters
(churches). For all three, there is an anticipated Control
Group rate between 15% and 25% [1,8]. The usual recom-
mendation is to take ICC between 0.002 and 0.05; ICC as
high as 0.10 is considered quite high. The PASS module
chooses a cluster size (number of individuals per cluster),
which determines the total sample size as cluster size X,
no. of clusters. Table 2 shows minimum detectable Inter-
vention Group rates for various cluster sizes, Control
Group rates, and ICC. The total sample size is driven by
Secondary Hypothesis 2, where the CG rate should be
around 0.20, and the intervention is expected to more
than double the rate. From the preceding Table 2, it ap-
pears safe to target between cluster sizes 3 and 4, for a
total sample size of 140 HIV-infected women. Using the
average of 6% of pregnant women infected with HIV, and
a possible 10% dropout rate (from our experience du-
ring scale up of community HIV testing), that would
require (140/0.06)/0.9 or approximately 2,700 total preg-
nant women (1,350 per group). Clearly, any interesting in-
crease in rate for the intervention group is detectable for
such a large total sample size for Hypotheses 1 and 2
(Table 2).






0.002 0.05 0.1 0.002 0.05 0.1 0.002 0.05 0.1
3 (120) 0.37 0.38 0.39 0.43 0.44 0.45 0.49 0.50 0.51
4 (160) 0.34 0.35 0.36 0.40 0.41 0.43 0.46 0.47 0.49
5 (200) 0.31 0.33 0.35 0.38 0.39 0.41 0.43 0.45 0.47
10 (400) 0.26 0.29 0.31 0.32 0.35 0.37 0.38 0.41 0.43
50 (2000) 0.20 0.24 0.27 0.25 0.30 0.33 0.31 0.36 0.39
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1,350 pregnant women in each arm of the study and
follow them through pregnancy and up to six weeks
post-delivery. Since pregnant women will be recruited at
different stages of pregnancy, we will need to end re-
cruitment five months after the study is open to re-
cruitment and allow time to follow the last recruited
pregnant women through nine months of pregnancy and
up to six to eight weeks post-delivery (approximately
eleven months). According to our review of infant bap-
tisms in churches in our proposed study area, there were
more than 50 churches with 200 infant baptisms per
year (an average of 16 per month) and 20 churches with
more than 100 infant baptisms per year (an average of 8
per month). We will need to recruit 15 of the large
churches and 5 of the small churches in each arm to
reach our sample size of 1,350 pregnant women in each
arm over a 5-month period. Table 1 illustrates the flexi-
bility we have with respect to both recruitment and attri-
tion. For example, if our recruitment goal is an average
of 16 pregnant women per month in a church with 200
infant baptisms per year, but it turns out we were only
able to recruit an average of 12 participants per month,
it means we will need to add and randomize 5 more
churches (15 + 5 = 20) to maintain our level of statistical
power. Note however, that our proposed primary ana-
lysis plan below is intent to treat (ITT), so we will ana-
lyze all participants who are randomized and who have
completed initial testing even if they drop out later.
Thus the above power analysis is conservative.Statistical methods
All three hypotheses test for differences in two binomial
proportions at follow-up. Clustering effects must be in-
corporated in the analysis since data collected on pari-
shioners within the same church could be expected to
exhibit correlation, while data collected on parishioners
in different churches should exhibit minimal correla-
tion. Generalized linear mixed models as implemented
in PROC GLIMMIX in SAS 9.3 [47] provide a rich set oftools for analyzing such data. Data will be analyzed with
that procedure using a logit link function and the binomial
distribution. These are multilevel models allowing incor-
poration of covariates and confounders for the individual
(such as age, household income, education level, previous
HIV testing, last menstrual period, marital status, employ-
ment status, male’s partners’ previous HIV test results,
and situational/contextual factors) and cluster-level (i.e.,
church) covariates and confounders such as size of church
and congregation type (Anglican or Catholic). For all three
hypotheses, a preliminary (and similar) analysis will model
the probability that an individual declines participation;
any significant predictors from that model will be used in
the main analysis to reduce confounding. Statistical sig-
nificance will be set as p-value <0.05 and tests will be
2-sided.
Trial status
HBI began in December 2012 at 40 churches in Enugu
State, Nigeria. To date, we have recruited 2,000 parti-
cipants of the expected 5,400. Participant recruitment
will be completed in August 2013, with each participant




In the first few months of implementing the study, we
encountered several ‘real world challenges’ that resulted
in some redesign of the protocol as originally conceived.
Church recruitment
One of the most common barriers to recruitment of
churches to participate in clinical trials involves the sus-
picion with which faith-based organization views the sci-
entific community. We had anticipated that this might
impact our recruitment, but to our surprise, we had
such a willingness and insistence to participate from
the priests that the 200 churches in the four dioceses
all wanted to participate in the study. They saw the
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crease the number of males who traditionally do not
attend church services regularly. Pregnant women in
churches that were not initially selected were reportedly
going to close by churches that were participating in the
program. To avoid the potential impact of unstructured
participation, we used a spoke-and-hub approach to in-
clude all the churches. Each initially selected church acts
as a coordinating hub for surrounding churches that fol-
lows the randomization group of their coordinating
church. This provided an organized method of expan-
ding the number of churches to accommodate the high
uptake without disrupting the randomization and follow-
up schedule in the study. Baby shower receptions were
held at the coordinating churches, while recruitment oc-
curs at each individual church.
Participant recruitment
Due to the high uptake of the program by churches and
subsequent uptake by pregnant women, Sundays initially
reserved for baby showers also became recruiting days.
This initially overwhelmed the study team. Activities ini-
tially planned for an estimated 25 participating pregnant
women and their male partners ended up being attended
by 100 potential participants. The study team initially
ran out of supplies of forms, mama packs, and blood
sample collection kits. It took a couple of months before
the study team was able to closely estimate attendance
at baby shower programs. Initially, some pregnant women
were turned away as consent forms were exhausted.
Data collection
Although the questionnaire was constructed at a sixth
grade reading level, administration of the questionnaire
became very time consuming as we encountered a rather
large number of individual participants who could not
read English or the local language. The utilization of local
church-based facilitators became very helpful in providing
basic translation of information.
Conclusions
The proposed study will test a congregation-based inter-
vention that uses a family-centered, culturally-appropriate
approach that relies on a widely distributed infrastructure
(religious institutions). If successful, this approach could
become a platform for multiple interventions aimed at im-
proving the quality of maternal child health services espe-
cially in hard-to-reach communities.
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